Bone density testing

Bone quality matters as much as bone density.

A stronger-looking number does not always mean stronger bone.

Many people first review diet, supplements, exercise, lifestyle, and labs before making medication decisions.

Medication may provide benefits for those with active bone metastases or may provide protection against bone metastases. See Bone Support and Protocol notes.

Core points

• DXA gives part of the picture.

• Bone quality is not fully captured by bone density alone.

• A baseline scan matters, especially before aromatase-inhibitor treatment.

• Repeat review at around 1–2 years is common during ongoing aromatase-inhibitor treatment.

• Higher bone density does not always mean bones are flexible and strong.

Women on aromatase inhibitors may need closer scan and bloodwork follow-up because hormone optimization is not straightforward in that setting.

Bisphosphonates or denosumab may sometimes be needed to slow bone loss in that group and may provide protection against bone metastases.

Premenopausal women using ovarian suppression plus an aromatase inhibitor may be at particular risk because they can spend longer without protective estrogen.

T-score basics

A T-score of -2.5 is the usual osteoporosis cutoff.

That reflects bone density about 30% below the average 30-year-old reference.

Ways to judge change over time

1. A two-year change of 5% or more suggests real bone loss.

2. A change around 2% may sit within expected scan error.

3. Actual bone density in g/cm² is more useful than the T-score alone.

4. Trabecular bone score can add useful context.

5. Bone-turnover markers help show whether bone is breaking down or rebuilding.

Trabecular bone score

Trabecular bone score, or TBS, is an indirect marker of bone microarchitecture.

It can help predict fragility fracture risk independently of the standard T-score.

It usually requires separate software and may not be included in a standard DXA report.

Some clinicians find it more useful than the T-score alone when bone quality is the main question.

Suggested ranges:

• ≥ 1.350 — normal

• 1.200–1.350 — partially degraded

• ≤ 1.200 — degraded

Common DXA pitfalls

• smaller bones can read differently and may fracture more easily

• osteoarthritis can falsely raise lumbar values

• scoliosis can distort interpretation

• positioning differences reduce year-to-year reliability

• different line placement changes the result

• automated reports may miss context

Finding a Qualified Practitioner

A certified densitometrist (who may also be a medical doctor) can provide the most informed evaluation of a DXA report. Many centers do not have a certified densitometrist on staff. To locate a certified densitometrist, go to the association website.

References

Trabecular bone score in osteoporosis evaluation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539023/

Trabecular bone score thresholds in postmenopausal women
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118821/

What’s in this hub

• Bone density testing: DXA interpretation, T-scores, trabecular bone score, and scan-reading pitfalls.

• Lab tests and root-cause workup: Baseline bloodwork, bone-turnover markers, and specialist follow-up tests.

• Diet and protein: Protein targets, mineral priorities, and oxalate-related food notes.

• Supplementation: Calcium, vitamin D, magnesium, K vitamins, creatine, and related support notes.

• Exercise and bone loading: Resistance work, impact loading, and bone-metastasis safety cautions.

• Vitamin K2 research notes: Reference links and caution notes on MK-4, MK-7, and arterial-calcification context.

• Genistein and bone health: Research notes on genistein for bone support, including oncology cautions.